Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C.

Hironao Okubo Hitoshi AndoYushi SorinEisuke NakaderaHiroo FukadaJunichi MorishigeAkihisa MiyazakiKenichi Ikejima

Published in: PloS one (2018)

Hepatic enhancement with gadoxetic acid was independently related to paritaprevir concentration and was an independent pretreatment factor in predicting hyperbilirubinemia. Gadoxetic acid-enhanced MR imaging can therefore be useful in determining the risk of paritaprevir-induced hyperbilirubinemia.

Keyphrases

magnetic resonance imaging
high glucose
diffusion weighted imaging
diabetic rats
drug induced
contrast enhanced
oxidative stress
magnetic resonance